Checkpoint inhibitors appear to reduce skin cancer precursors. However, reports also mention other factors, such as higher UPF intake and cholesterol, which may be related to cancer precursors, although it is unclear how these factors are connected to the use of checkpoint inhibitors. Immunotherapy is also being explored for its potential to reduce skin cancer precursors and may be more effective than chemotherapy for certain types of skin cancer.